AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoglim-M3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (1000mg)

Overview Endoglim-M3 Tablet SR

Diabetac-Duo SR tablets are classified as antidiabetic medications, combining two active ingredients for managing type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabetac-Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is vital, even with well-controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are crucial for prevention. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Endoglim-M3 Tablet SR

No text provided. Please provide the text you wish to be rewritten.

Uses of Endoglim-M3 Tablet SR

Managing type 2 diabetes

Major Benefits of Endoglim-M3 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Endoglim-M3 SR tablets should be administered with food.

Common Side effects of Endoglim-M3 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Endoglim-M3 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Endoglim-M3 SR tablets should be taken with a meal.

How Endoglim-M3 Tablet SR works:

Endoglim-M3 SR tablets combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Endoglim-M3 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Endoglim-M3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Endoglim-M3 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Endoglim-M3 SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Endoglim-M3 SR tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Endoglim-M3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a low dosage; however, its use is contraindicated in individuals with severe liver disease.

What if you forget to take Endoglim-M3 Tablet SR :

Should you forget a dose of Endoglim-M3 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Endoglim-M3 Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Endoglim-M3 Tablet SR

Retain this medication within its original, sealed container or packaging. Store as directed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Endoglim-M3 Tablet SR. Also termed Metformin-associated lactic acidosis (MALA), this rare but dangerous complication is particularly risky for individuals with impaired kidney function, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Endoglim-M3 Tablet SR and seek immediate medical attention.
Endoglim-M3 SR tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride's action involves stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves cellular insulin responsiveness. This formulation is unsuitable for individuals with type 1 diabetes.
Endoglim-M3 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Prolonged Endoglim-M3 Tablet SR administration can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may manifest as anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive strategies proposed by some researchers involve annual supplemental Vitamin B12 intake.
Indeed, Endoglim-M3 Tablet SR may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar can encompass nausea, headache, irritability, increased hunger, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol while taking Endoglim-M3 Tablet SR is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Furthermore, this combination elevates the likelihood of lactic acidosis.
Endoglim-M3 Tablet SR
81
MRP 99
18% off